Clelia Pellicano

Fondazione Santa Lucia — Italy

Medicine · Health Sciences

24h-index1.7kcitations76works6.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(47), Neurological disorders and treatments(29), Botulinum Toxin and Related Neurological Disorders(9), Restless Legs Syndrome Research(7), Multiple Sclerosis Research Studies(6)

Publications76 total

Global network and local vulnerabilities underlie brain atrophy across Parkinson’s disease stages
Brain·2025Open Access
Contribution of Cerebellar Glutamatergic and GABAergic Systems in Premotor and Early Stages of Parkinson’s Disease
International Journal of Molecular Sciences·2025Open Access
Pauses as a Quantitative Measure of Linguistic Planning Challenges in Parkinson’s Disease
Brain Sciences·2025Open Access
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation
npj Parkinson s Disease·2025Open Access
Contribution of Cerebellar Glutamatergic and GABAergic Systems in Premotor and Early Stages of Parkinson’s Disease
Preprints.org·2025Open Access
Pauses as a Quantitative Measure of Linguistic Planning Challenges in Parkinson’s Disease
Preprints.org·2025Open Access
Opicapone in Parkinson’s disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefit
Journal of Neural Transmission·2025· 2 citedOpen Access
Pharmacogenetics or predictive genetics? APOE testing blurs the lines
Frontiers in Pharmacology·2025Open Access
Effects of <i>GBA1</i> Variants in Patients With Parkinson's Disease and Levodopa–Carbidopa Intestinal Gel: A Nation‐Wide, Multicenter, Longitudinal, “Real‐World” Study. The <scp>EPIC</scp> Study
European Journal of Neurology·2025· 2 citedOpen Access
Convergent large-scale network and local vulnerabilities underlie brain atrophy across Parkinson’s disease stages: a worldwide ENIGMA study
2025· 1 citedOpen Access
Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s disease
Brain Communications·2025· 5 citedOpen Access
Evaluating conversion from mild cognitive impairment to Alzheimer’s disease with structural MRI: a machine learning study
Brain Communications·2024· 2 citedOpen Access
A worldwide study of subcortical shape as a marker for clinical staging in Parkinson’s disease
npj Parkinson s Disease·2024· 8 citedOpen Access
A worldwide study of white matter microstructural alterations in people living with Parkinson’s disease
npj Parkinson s Disease·2024· 21 citedOpen Access
Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
The Lancet Neurology·2024· 60 cited
A Worldwide Study of White Matter Microstructural Alterations in People Living with Parkinson’s Disease
2024· 1 citedOpen Access
Cerebellar Volume and Disease Staging in Parkinson's Disease: An <scp>ENIGMA‐PD</scp> Study
Movement Disorders·2023· 27 citedOpen Access
Narrative discourse production in Parkinson’s disease: Decoupling the role of cognitive-linguistic and motor speech changes
Heliyon·2023· 11 citedOpen Access
Gastrointestinal Autonomic Disorders
2023· 1 cited
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI
Sleep Medicine·2022· 11 cited
page 1 of 4Next →

Frequent Co-authors

Francesco E. Pontieri(28), Gianfranco Spalletta(22), Francesca Assogna(19), Carlo Caltagirone(12), Francesca Romana Buttarelli(9), Dario Benincasa(7), Morena Giovannelli(6), Lucia Macchiusi(6), Mariangela Pierantozzi(6), Alessandro Stefani(6), Joan Ohayon(5), Francesca Bagnato(5), Luca Cravello(5), Fabrizio Piras(5), Max A. Laansma(5), Sarah Al–Bachari(5), Fernando Cendes(5), John C. Dalrymple‐Alford(5), Odile A. van den Heuvel(5), Corey T. McMillan(5)